Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead

Metastatic melanoma is the most aggressive and difficult to treat type of skin cancer, with a survival rate of less than 10%. Metastatic melanoma has conventionally been considered very difficult to treat; however, recent progress in understanding the cellular and molecular mechanisms involved in th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cells
Glavni autori: Soltantoyeh, Tahereh, Akbari, Behnia, Karimi, Amirali, Mahmoodi Chalbatani, Ghanbar, Ghahri-Saremi, Navid, Hadjati, Jamshid, Hamblin, Michael R., Mirzaei, Hamid Reza
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8230324/
https://ncbi.nlm.nih.gov/pubmed/34207884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10061450
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items